Autosomal dominant von Willebrand disease type 2M

Acta Haematol. 2009;121(2-3):139-44. doi: 10.1159/000214854. Epub 2009 Jun 8.

Abstract

von Willebrand disease (VWD) type 2M is a distinct entity and clearly differs from type 1. The genotype-phenotype correlation for cases with ristocetin cofactor activity (RCo)/antigen (Ag) ratios <0.60 is clear, whereas the von Willebrand factor (VWF):collagen binding (CB)/VWF:Ag ratio is normal in VWD 2M. Typical laboratory features of VWD type 2 M are decreased ristocetin-induced platelet aggregation in the presence of a normal or near normal VWF multimeric pattern on a low-resolution agarose gel, a poor response to desmopressin (DDAVP) of VWF:RCo, and a good response of both VWF:CB and VWF:Ag to DDAVP. The phenotypic definition of VWD type 2M may need to be more stringent and should be the subject of an international standardization initiative.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bleeding Time
  • Blood Protein Electrophoresis
  • Collagen / analysis
  • Genes, Dominant
  • Genotype
  • Humans
  • Models, Molecular
  • Molecular Weight
  • Mutation, Missense
  • Phenotype
  • Platelet Aggregation / drug effects
  • Point Mutation
  • Protein Structure, Quaternary
  • Protein Structure, Tertiary
  • Terminology as Topic
  • von Willebrand Diseases / classification
  • von Willebrand Diseases / diagnosis
  • von Willebrand Diseases / genetics*
  • von Willebrand Factor / analysis
  • von Willebrand Factor / chemistry
  • von Willebrand Factor / genetics*

Substances

  • von Willebrand Factor
  • Collagen